Simponi Simponi Aria — Sales to customers (Note 9)
Products & Services · Sales to customers (Note 9)Johnson & Johnson Simponi Simponi Aria — Sales to customers (Note 9) decreased by 0.7% to $1.37B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 32.9%, from $1.03B to $1.37B. Over 2 years (FY 2021 to FY 2024), Simponi Simponi Aria — Sales to customers (Note 9) shows relatively stable performance with a -1.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market adoption and sustained demand for the therapy, while a decrease may signal increased competition from biosimilars or a shift in clinical treatment standards.
Detailed definition
This metric represents the total net revenue generated from the sale of Simponi and Simponi Aria, which are biologic the...
Peer comparison
Comparable to revenue metrics for specific biologic or specialty pharmaceutical product lines at peer companies like AbbVie or Amgen.
jnj_segment_simponi_simponi_aria_sales_to_customers_note_9Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.12B | $1.17B | $1.14B | $1.23B | $1.14B | $1.13B | $1.09B | $1.07B | $1.26B | $1.11B | $1.07B | $1.03B | $1.17B | $1.32B | $1.38B | $1.37B |
| QoQ Change | — | +3.9% | -2.2% | +7.3% | -6.9% | -0.7% | -3.7% | -1.6% | +17.1% | -12.0% | -3.0% | -3.8% | +12.9% | +13.0% | +4.9% | -0.7% |
| YoY Change | — | — | — | — | +1.5% | -3.0% | -4.5% | -5.9% | +11.0% | — | +0.0% | -17.9% | — | +19.0% | +28.7% | +32.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's simponi simponi aria — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported simponi simponi aria — sales to customers (note 9) of $1.37B in Q3 2025.
- How has Johnson & Johnson's simponi simponi aria — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's simponi simponi aria — sales to customers (note 9) increased by 32.9% year-over-year, from $1.03B to $1.37B.
- What is the long-term trend for Johnson & Johnson's simponi simponi aria — sales to customers (note 9)?
- Over 2 years (2021 to 2024), Johnson & Johnson's simponi simponi aria — sales to customers (note 9) has grown at a -1.2% compound annual growth rate (CAGR), from $4.49B to $4.38B.
- What does simponi simponi aria — sales to customers (note 9) mean?
- The total net revenue generated from the sales of Simponi and Simponi Aria biologic therapies.